Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India

Author:

Im Justin1ORCID,Islam Md Taufiqul2,Ahmmed Faisal2,Kim Deok Ryun1,Tadesse Birkneh Tilahun1,Kang Sophie1,Khanam Farhana2ORCID,Chowdhury Fahima2,Ahmed Tasnuva2,Firoj Md Golam2,Aziz Asma Binte1ORCID,Hoque Masuma2,Jeon Hyon Jin13,Kanungo Suman4,Dutta Shanta4,Zaman Khalequ2,Khan Ashraful Islam2,Marks Florian1356ORCID,Kim Jerome H1,Qadri Firdausi2,Clemens John D1278

Affiliation:

1. International Vaccine Institute , Seoul , Republic of Korea

2. International Centre for Diarrheal Disease Research , Dhaka , Bangladesh

3. Cambridge Institute of Therapeutic Immunology and Infectious Disease, School of Clinical Medicine, University of Cambridge , Cambridge , UK

4. ICMR–National Institute of Cholera and Enteric Diseases , Kolkata , India

5. Madagascar Institute for Vaccine Research, University of Antananarivo , Antananarivo , Madagascar

6. Heidelberg Institute of Global Health, University of Heidelberg , Heidelberg , Germany

7. Fielding School of Public Health , University of California–Los Angeles, Los Angeles, California , USA

8. Vaccine Innovation Center, School of Medicine, Korea University , Seoul , Republic of Korea

Abstract

Abstract Background Oral cholera vaccine (OCV) and incremental improvements in household water, sanitation, and hygiene (WASH) within cholera-endemic areas can reduce cholera risk. However, we lack empiric evaluation of their combined impact. Methods We evaluated a cluster-randomized, placebo-controlled trial of OCV (Shanchol) in Kolkata, India. The study population included 108 777 individuals, and 106 879 nonpregnant individuals >1 year of age were eligible to receive 2 doses of OCV or placebo. We measured cholera risk in all household members assigned to OCV vs placebo and in all members of households with “Better” vs “Not Better” WASH, where WASH was classified according to validated criteria. Protection was measured by Cox proportional hazard models. Results Residence in an OCV household was associated with protective effectiveness (PE) of 54% (95% CI, 42%–64%; P < .001) and was similar regardless of Better (PE, 57%; 95% CI, 26%–75%; P = .002) or Not Better (PE, 53%; 95% CI, 40%–64%; P < .001) household WASH. Better WASH household residence was associated with PE of 30% (95% CI, 5%–48%; P = .023) and was similar in OCV (PE, 24%; 95% CI, −26% to 54%; P = .293) and placebo (PE, 29%; 95% CI, −3% to 51%; P = .069) households. When assessed conjointly, residence in OCV households with Better WASH was associated with the greatest PE against cholera at 69% (95% CI, 49%–81%; P < .001). Conclusions These findings suggest that the combination of a vaccine policy and improved WASH reduces cholera risk more than either would alone, although the magnitude of either intervention was not affected by the other. Future randomized trials investigating OCV and WASH interventions separately and together are recommended to further understand the interaction between OCV and WASH.

Funder

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3